Patrick Mallon to Prospective Studies
This is a "connection" page, showing publications Patrick Mallon has written about Prospective Studies.
Connection Strength
0.112
-
The COVIRL-001 Trial: A multicentre, prospective, randomised trial comparing standard of care (SOC) alone, SOC plus hydroxychloroquine monotherapy or SOC plus a combination of hydroxychloroquine and azithromycin in the treatment of non- critical, SARS-CoV-2 PCR-positive population not requiring immediate resuscitation or ventilation but who have evidence of clinical decline: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 05 25; 21(1):430.
Score: 0.035
-
HIV and cardiovascular disease: defining the unmeasured risk. Lancet HIV. 2018 06; 5(6):e267-e269.
Score: 0.031
-
Switching from abacavir to tenofovir disoproxil fumarate is associated with rises in soluble glycoprotein VI, suggesting changes in platelet-collagen interactions. AIDS. 2018 04 24; 32(7):861-866.
Score: 0.031
-
Cohort profile: The Pharmacokinetic and clinical Observations in PeoPle over fiftY (POPPY) study. Int J Epidemiol. 2018 10 01; 47(5):1391-1392e.
Score: 0.008
-
Predictors of longitudinal change in bone mineral density in a cohort of HIV-positive and negative patients. AIDS. 2017 03 13; 31(5):643-652.
Score: 0.007